...索非布韦（sofosbuvir,Sovaldi）和Harvoni（ledipasvir/sofosbuvir）的说明书信息,将症状性心动过缓（symptomatic bradycardia）的风险写进Harvoni和Sovaldi的药品标签中.
基于54个网页-相关网页
If symptomatic bradycardia goes untreated, it could lead to death, but that's easy enough to prevent–just go see your doctor.
由心动过缓引发的症状治疗无效时会导致死亡，但是，这样的情况也相当容易预防——看医生就得嘞！
The team "strongly recommends" electrocardiogram (ECG) monitoring of all such patients to look for the development of atrioventricular block and symptomatic bradycardia.
研究小组强烈的推荐对所有患者心电图监护去寻找房室传导阻滞和心动过缓的症状。
Results The total effective rate was 86.8%, 3 cases of bradycardia during treatment. 4 cases of hypotension. The symptomatic treatment of these symptoms are relieved.
结果总有效率为86.8%，治疗期间3例出现心动过缓，4例出现低血压，经对症处理后上述症状均缓解。
应用推荐